The Use of a Bedside Assay for Plasma B-type Natriuretic Peptide as a Biomarker in the Management of Patent Ductus Arteriosus in Premature Neonates
Authors:
- Patrick A. FlynnPFPatrick A. Flynn
- Ralph L. da GracaRGRalph L. da Graca
- Peter A.M. AuldPAPeter A.M. Auld
- Mirjana NesinMNMirjana Nesin
- Charles S. KleinmanCKCharles S. Kleinman
- 1 July 2005
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 147 (1) , 38-42
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Use of Biomarkers in the Management of Heart FailureCirculation, 2003
- Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infantsClinical Science, 2002
- Cerebral blood flow velocity and pulsation in neonatal respiratory distress syndrome and periventricular hemorrhagePediatric Neurology, 1997
- C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brainBiochemical and Biophysical Research Communications, 1990
- Real-time Doppler color flow mapping for detection of patent ductus arteriosusJACC, 1986
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986
- Risk Factors for Developing and Dying from Necrotizing EnterocolitisJournal of Pediatric Gastroenterology and Nutrition, 1986
- Persistent ductus arteriosus complicating the respiratory distress syndrome.Archives of Disease in Childhood, 1977
- Echocardiographic Assessment of Ductus Arteriosus Shunt in Premature InfantsCirculation, 1974
- Respiratory Distress from Patent Ductus Arteriosus in the Premature NewbornAnnals of Surgery, 1973